Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

SCALE™ IBT

Novo Nordisk · Phase 3 · Completed · Enrollment 282

NCT02963935

ArmPopulationDoseWeeksEstimandWeight change
LiraglutideObesity or overweightn/r56Efficacyn/r
PlaceboObesity or overweightn/r56Efficacyn/r
Liraglutide 3.0 mg, in trialObesity or overweight3.0 mg56ITTn/r
Placebo, in trialObesity or overweightn/r56ITTn/r